<DOC>
	<DOCNO>NCT00044408</DOCNO>
	<brief_summary>The purpose protocol determine investigational drug know LY333531 effective treat nerve malfunction diabetes .</brief_summary>
	<brief_title>Treatment Symptomatic Peripheral Neuropathy Patients With Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Ruboxistaurin</mesh_term>
	<criteria>Patients must type I type II Diabetes Mellitus . Have clinically diagnose positive sensory symptom numbness , lancinating pain , burn pain , ache pain , allodynia prickle sensation present great 5 year stable 6 month . Has HbA1C less equal 12 % . Patients HbA1C great 9 % must insulin therapy . Must 18 year old . Be able visit doctor 's office approximately 3 time maximum 6week period determine continue study . History significant liver problem . Have poor kidney function . Drink excess alcohol abuse drug . Have recently participate currently participate Medical study receive experimental drug . Are woman pregnant breastfeeding , intend become pregnant within next 2 year woman use effective birth control .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>